Substituted hepta-1,6-dien-3-ones with green/fruity odours green/galbanum olfactophore model
摘要:
Following an analysis of available SAR data on green/galbanum-smelling molecules, a series of new 2-substituted hepta-1,6-dien-3-ones and their analogues were prepared and their olfactory properties evaluated. The study allowed to select efficient new odourants-potential substitutes for natural galbanum oil-and to generate an olfactophore model for the green/galbanum note. (C) 2003 Elsevier Science Ltd. All rights reserved.
A Rh(III)-Catalyzed Formal [4+1] Approach to Pyrrolidines from Unactivated Terminal Alkenes and Nitrene Sources
作者:Sumin Lee、Honghui Lei、Tomislav Rovis
DOI:10.1021/jacs.9b07012
日期:2019.8.14
formal [4+1] approach to pyrrolidines from readily available unactivated terminalalkenes as 4-carbon partners. The reaction provides a rapid construction of various pyrrolidine containing structures, especially for the diastereoselective synthesis of spiro-pyrrolidines. Mechanistic investigation suggests a Rh(III)-catalyzed intermolecular aziridination of the alkene and subsequent acid-promoted ring expansion
There is provided a GRF compound or analog thereof for use in improving daytime vigilance and/or cognitive function in a subject.
本文提供了一种 GRF 化合物或其类似物,用于改善受试者的白天警觉性和/或认知功能。
COMPOUNDS USEFUL AS MODULATORS OF TRPM8
申请人:Senomyx, Inc.
公开号:EP2958897A2
公开(公告)日:2015-12-30
Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering From Wasting
申请人:Lussier Bruno
公开号:US20080167222A1
公开(公告)日:2008-07-10
The present invention provides methods for using growth hormone releasing factor analogs of the formula (A), X-GRF Peptide, and pharmaceutically acceptable salts thereof, for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
申请人:Loughrey Helen
公开号:US20080249017A1
公开(公告)日:2008-10-09
Stabilized solid and liquid pharmaceutical formulations comprising a GHRH molecules as active ingredient, and more particularly GHRH analogs including [trans-3-hexenoyl]hGHRH (1-44) amide, are disclosed. The formulation comprises an anionic surfactant and a non-reducing sugar, and has a pH of about 4.0 to about 7.5. Also disclosed is the use of the formulation for the treatment of various conditions, methods of preparing the formulation, as well as kits containing it.